China's first specific anti COVID-19 drug was approved by the Food and Drug Administration for marketing. The professor of the R&D team explained the principle of anti COVID-19 specific drugs: antibodies are the natural weapons of the human body. They "look for a needle in a haystack", screened two antibodies with strong blocking power against COVID-19, and let them play a combined punch together.
"The drug takes the form of intravenous drip and takes effect immediately after being injected into the body", which can reduce the hospitalization rate and mortality rate of 80% of high-risk COVID-19 outpatients, mainly for treatment.
Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!